This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Explore which altcoins have strong teams and performance, highlighting projects with solid development and momentum. Learn how team credibility aligns with price trends and long-term potential.
28,391 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...